Agranulocytosis - 140 Studies Found
Recruiting |
: Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell Transplantation :
: 2012-07-04 :
|
Completed |
: A Study of Empirical Antifungal Therapy With Itraconazole : Neutropenia : 2012-10-11 : Drug: Itraconazole Itraconazole intravenous (IV) 200 mg twice daily for 2 days, a total of 4 doses and t |
Completed |
: The Utility of Multiplex PCR for Detection of DNA in Neutropenic Patients With Hematological Malignancies : Neutropenia : 2012-08-16 |
Completed |
: Effectiveness of Reduced GCSF Dosing in Patients With a Low to Moderate Risk of Febrile Neutropenia : Breast Cancer : 2012-07-27 : Drug: GCSF administration on days 8 and 12 after chemotherapy |
Completed |
: Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients : Neutropenia : 2012-07-02 : Drug: Pegfilgrastim Single SC injection of the appropriate dose of drug ranging from 30 mcg/kg to 200 mc |
Completed |
: Micafungin Prevention Study for Invasive Fungal Disease in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation :
: 2011-08-09 : Drug: micafungin Eligible patients who provided informed consent form will be administered micafungin at |
Terminated |
: SubCutaneous (SC) Versus Intravenous (IV) Granulocyte Colony Stimulating Factors (G-CSF) for the Treatment of Neutropenia in Hospitalized Haemato-oncological Patients : Leukemia : 2010-10-14 : Drug: filgrastim 5 mcg/kg (rounded to 300 mcg or 480 mcg) |
Terminated |
: Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation :
|
Completed |
: Neugranin in Breast Cancer Patients Receiving Doxorubicin/Docetaxel (NEUGR-003) : Chemotherapy-induced Neutropenia : 2010-05-04 :
|
Completed |
: A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen : Neoplasms (no Otherwise Specified) : 2010-04-13 : Drug: LENOGRASTIM (GRANOGYTE 34) Pharmaceutical form: solution Route of administration: intravenous Dose |